HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Return
11.46%
This Quarter Return
+12.56%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.18B
AUM Growth
+$438M
(+25%)
Cap. Flow
+$297M
Cap. Flow
% of AUM
13.64%
Top 10 Holdings %
Top 10 Hldgs %
65.42%
Holding
52
New
13
Increased
11
Reduced
11
Closed
14
Top Buys
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$272M |
| 2 |
Edwards Lifesciences
EW
|
$118M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$112M |
| 4 |
AET
Aetna Inc
AET
|
$93.9M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$83.5M |
Top Sells
| 1 |
Quest Diagnostics
DGX
|
$103M |
| 2 |
QGENF
QIAGEN NV
QGENF
|
$79.9M |
| 3 |
Danaher
DHR
|
$75.8M |
| 4 |
Incyte
INCY
|
$74.3M |
| 5 |
Zimmer Biomet
ZBH
|
$69.6M |
Sector Composition
| 1 | Healthcare | 87.1% |
| 2 | Financials | 9.22% |
| 3 | Materials | 1.56% |
| 4 | Consumer Staples | 0% |